Derm-Biome Pharmaceuticals, Inc. 报告银屑病临床前研究的积极结果

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] VANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that one of its topical drugs produced significant, and dose dependent inhibitory effects in a well established mouse […]

Derm-Biome Pharmaceuticals, Inc 筹集种子前资金,成立专注于慢性炎症疾病的新公司

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin diseases and healthy ageing, is pleased to announce that it has raised $500,000 in pre-seed funding, monies that will allow it to advance its anti-aging (skin […]

Derm-Biome Pharmaceuticals, Inc. 报告特应性皮炎临床前研究的积极结果

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] VANCOUVER, British Columbia, March 24, 2020 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that one of its topical drugs produced significant, and dose dependent inhibitory effects in a well established […]

皮肤健康初创公司 Derm-Biome Pharmaceuticals, Inc. 获得加拿大政府资助

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text]VANCOUVER, British Columbia, July 09, 2019 (GLOBE NEWSWIRE) — Derm-Biome Pharmaceuticals, Inc, a private Vancouver based start-up biopharmaceutical company focused on skin health, is excited to announce that it will receive up to $149,000 in research and development funding from the National Research Council of Canada Industrial Research […]

Derm-Biome Pharmaceuticals Inc 寻求合作者来测试有前景的抗肿瘤化合物对狗、猫和马的皮肤癌的治疗作用。

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text] March 20, 2019 VANCOUVER, British Columbia — Derm-Biome Pharmaceuticals Inc, a Vancouver based start-up biopharmaceutical company, will be reaching out to the world’s top veterinary researchers and veterinary schools for collaborative opportunities to show efficacy of its lead compound NVX-207, in the underserved area of cancers in […]

Derm-Biome Pharmaceuticals Inc. 宣布与哈佛医学院开展激动人心的合作

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_empty_space][vc_column_text] February 22, 2019 VANCOUVER, British Columbia — Derm-Biome Pharmaceuticals Inc, a Vancouver based start-up biopharmaceutical company, is excited to announce that it will be collaborating with Dr. Anna Mandinova and the Department of Dermatology at Harvard Medical School. “I reached out to Poul (Dr. Sorensen) when I […]

Derm-Biome Pharmaceuticals Inc. 开始针对皮肤微生物组目标测试其专有化合物。

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] October 26, 2018 VANCOUVER, British Columbia — Vancouver based microbiome startup Derm-Biome Pharmaceuticals Inc. is excited to announce that it has contracted the Centre for Drug Research and Development (CDRD) to commence testing its patented compounds on various pathogens. Lead compound DB-207 shows significant potential in patients […]

Novelix 制药公司 – 公司概况

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column][vc_column_text] October 23, 2009 Novelix Pharmaceuticals, Inc. (Novelix), is a private, La Jolla based, biotechnology company committed to developing innovative, proprietary, dermatology products with large market potential to treat serious skin diseases. The company’s main focus is the development of NVX-207, a novel, topical drug candidate with the […]